搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
eLife
2 小时
Study shows how genetic defects in Toxoplasma are rescued by co-infection
Toxoplasma gondii parasites can use secreted factors to compensate for genetic defects in neighbouring parasites, highlighting a limitation of pooled CRISPR screens.
Samaa
3 小时
Zebrafish, lizards hold key to restore hearing, study reveals
This discovery sheds light on potential mechanisms that could help humans recover from hearing loss and balance disorders.
5 小时
on MSN
Weaponizing bacterial viruses to combat superbugs
Researchers from the University of Illinois have reported complementary discoveries that will improve scientists' ...
5 小时
Editas Medicine盘中异动 大幅下挫5.38%报2.11美元
北京时间2024年12月11日00时32分,Editas Medicine, Inc.(EDIT.us)股票出现异动,股价快速下挫5.38%。截至发稿,该股报2.11美元/股,成交量51.2677万股, 换手率 0.62%,振幅4.67%。
labiotech
7 小时
Biotech in 2024: A retrospective
In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...
agdaily
8 小时
Looking at the biggest breakthroughs in agriculture for 2024
Agriculture has always been an industry rooted in tradition, yet its adaptability and commitment to progress are now ...
15 小时
Analysts Conflicted on These Healthcare Names: Revance Therapeutics (RVNC), Syndax ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Revance Therapeutics (RVNC – Research ...
Nature
22 小时
How CRISPR patent issues block Indian farmers from accessing biotech benefits
Scientists in Asia and Africa are racing to discover hardier crop varieties using gene editing tools. But patent restrictions ...
STAT
23 小时
Johnson & Johnson seeks first drug approval for treatment of smoldering myeloma
Market analysts liked the news, with analysts for Cantor writing that this was a “best-case data update.” ...
1 天
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual ...
Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated safety profile using a ...
AZoLifeSciences on MSN
1 天
New Class of CRISPR-Cas Enzymes for Precise Genome Editing
Recent research published in the journal “Science Bulletin” detailed the creation of a tool called ChCas12b that can ...
WBUR
1 天
How genetically engineered mice could stop the spread of Lyme disease
Kevin Esvelt, an associate professor at the MIT Media Lab and the inventor of CRISPR-based gene drive, joins Radio Boston.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈